This cohort study investigates whether white matter hyperintensity in individuals with Alzheimer disease is more likely to be associated with neurodegeneration and parenchymal and vessel amyloidosis than with systemic vascular risk.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Tau Oligomer–Containing Synapses Engulfed by Microglia and Astrocytes in Alzheimer Disease | 0 | 7.6 | 01-11-2023 |
| 2 | Blood Biomarkers to Detect Alzheimer Disease in Primary and Secondary Care | 0 | 5.63 | 15-10-2024 |
| 3 | Association Between Slow-Wave Sleep Loss and Incident Dementia | 0 | 12.27 | 01-12-2023 |
| 4 | p-Tau 217 and Aβ42/40 to Predict Early Brain Aβ Accumulation | 0 | 15.37 | 01-09-2024 |
| 5 | Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis | 0 | 7.35 | 01-12-2023 |
| 6 | Deferiprone in Alzheimer Disease | 0 | 10.42 | 01-01-2025 |
| 7 | Study shows a blood test can help identify healthy people at high risk for Alzheimer's disease | 0 | 7 | 15-07-2026 |
| 8 | Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis | 0 | 8.77 | 01-04-2024 |
| 9 | Blood test could help identify people at high risk for Alzheimer's disease, study shows | 2 | 7 | 15-07-2026 |
| 10 | Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage | 0 | 11.73 | 01-04-2024 |